Dominican Rep.: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Dominican Rep. pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$102.5 million | 43.9% |
| 3004 Medicaments | US$73.5 million | 31.5% |
| 3006 Pharmaceutical goods | US$56.8 million | 24.3% |
| 3002 Human blood | US$441,000 | 0.2% |
| 3003 Medicaments | US$197,000 | 0.1% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$1,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$82.7 million | 35.4% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$56.7 million | 24.3% |
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$53.0 million | 22.7% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$19.7 million | 8.5% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$16.4 million | 7.0% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$2.2 million | 1.0% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$1.0 million | 0.4% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$467,000 | 0.2% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$433,000 | 0.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$290,000 | 0.1% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$653.2 million | 78.7% |
| 3002 Human blood | US$112.3 million | 13.5% |
| 3006 Pharmaceutical goods | US$29.8 million | 3.6% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$26.7 million | 3.2% |
| 3003 Medicaments | US$5.5 million | 0.7% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$3.0 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$583.3 million | 70.2% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$56.2 million | 6.8% |
| 300220 Vaccines: for human medicine | US$33.2 million | 4.0% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$22.3 million | 2.7% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$17.7 million | 2.1% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$16.6 million | 2.0% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$12.8 million | 1.5% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$12.5 million | 1.5% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$11.1 million | 1.3% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$8.9 million | 1.1% |
Shares are of Dominican Rep.'s pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Dominican Rep.'s trade.
More Dominican Rep. products
- 27 Mineral fuels, mineral oils and products of their distillation
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 87 Vehicles
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 85 Electrical machinery and equipment and parts thereof
- 39 Plastics and articles thereof
- 71 Natural, cultured pearls
- 24 Tobacco and manufactured tobacco substitutes
- 72 Iron and steel
- 10 Cereals
- 73 Iron or steel articles
- 48 Paper and paperboard
Dominican Rep. pharmaceutical products: questions and answers
How much pharmaceutical products does Dominican Rep. export?
In 2024, Dominican Rep. exported US$233.4 million of pharmaceutical products (HS chapter 30), 1.6% of its total exports. That ranks it 64 of 213 exporting countries in the data.
What are Dominican Rep.'s biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Wadding, gauze, bandages (dressings, adhesive plasters… (3005, US$102.5 million), Medicaments (3004, US$73.5 million), Pharmaceutical goods (3006, US$56.8 million).
How much pharmaceutical products does Dominican Rep. import?
In 2024, Dominican Rep. imported US$830.4 million of pharmaceutical products (HS chapter 30), 2.5% of its total imports. That ranks it 73 of 226 importing countries in the data.
What are Dominican Rep.'s biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$653.2 million), Human blood (3002, US$112.3 million), Pharmaceutical goods (3006, US$29.8 million).
